Search
for
Sort by
Research 721–750 of 1000+
- JAK Inhibitors for Treatment of Alopecia Areata
- Platelet-rich plasma as a potential treatment for noncicatricial alopecias
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- Hair Loss, Insulin Resistance, and Heredity in Middle-aged Women. a Population-based Study
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Genetic Basis of Alopecia Areata
- Quality of life in children and adolescents with alopecia areata—A systematic review
- Race and Alopecia Areata amongst US Women
- <i>In vivo </i>CD44‐CD49d complex formation in autoimmune disease has consequences on T cell activation and apoptosis resistance
- “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata
- Genomewide analysis of copy number variants in alopecia areata in a Central European cohort reveals association with <i>MCHR2</i>
- Harlequin ichthyosis (ichq): a juvenile lethal mouse mutation with ichthyosiform dermatitis.
- Serum granulysin as a possible key marker of the activity of alopecia areata
- Efficacy of Korean Red Ginseng in the Treatment of Alopecia Areata
- Alopecia and platelet-derived therapies
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss
- The Role of Diet as an Adjuvant Treatment in Scarring and Nonscarring Alopecia
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- Platelet-Rich Plasma in Alopecia Areata—A Steroid-Free Treatment Modality: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- A “hair‐raising” history of alopecia areata
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata
- Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients